Theracryf Plc (TCF.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 82 | -379 | -91 | 110 | -39 |
| Other Working Capital | -493 | -491 | 332 | -86 | -85 |
| Other Operating Activity | -1,956 | -2,126 | -4,368 | -2,608 | -2,802 |
| Operating Cash Flow | $-2,367 | $-2,996 | $-4,127 | $-2,584 | $-2,926 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | -1 | -3 | -5 |
| Net Acquisitions | -75 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -6,000 |
| Sale Of Investment | N/A | 0 | 4,520 | N/A | N/A |
| Other Investing Activity | -2,000 | 0 | 98 | 1,504 | 0 |
| Investing Cash Flow | $-2,075 | $0 | $4,617 | $1,501 | $-6,005 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,152 | N/A | N/A | 0 | 11,110 |
| Other Financing Activity | -605 | 0 | 0 | 0 | -717 |
| Financing Cash Flow | $4,547 | $N/A | $N/A | $0 | $10,393 |
| Beginning Cash Position | 2,004 | 5,000 | 4,510 | 5,593 | 4,131 |
| End Cash Position | 2,109 | 2,004 | 5,000 | 4,510 | 5,593 |
| Net Cash Flow | $105 | $-2,996 | $490 | $-1,083 | $1,462 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,367 | -2,996 | -4,127 | -2,584 | -2,926 |
| Capital Expenditure | N/A | N/A | -1 | -3 | -5 |
| Free Cash Flow | -2,367 | -2,996 | -4,128 | -2,587 | -2,931 |